Evidence map›Paper›PMID 23289920›Full record

Trial reportParasites & vectors2013

Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania, and effect of single-dose albendazole, nitazoxanide and albendazole-nitazoxanide.

Benjamin Speich, Hanspeter Marti, Shaali M Ame, Said M Ali, Isaac I Bogoch, Jürg Utzinger, Marco Albonico, Jennifer Keiser

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Parasites & vectors, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Antiamoebic drugs for treating amoebic colitis.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Trial
  3. The activity of combinations of currently used antigiardial drugs against Giardia duodenalis.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026
    Article
  4. Molecular Epidemiology ofMicroorganisms · 2025
    Article
  5. Article
  6. Article
  7. Parasite epidemiology and control · 2025
    Article
  8. Article
  9. Article
  10. Molecular identification ofVeterinary world · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Prevalence ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Ascariasis, Amebiasis and Giardiasis in Mexican children: distribution and geographical, environmental and socioeconomic risk factors.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Benjamin SpeichDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, PO Box, CH-4002 Basel, Switzerland.
Hanspeter Marti
Shaali M Ame
Said M Ali
Isaac I Bogoch
Jürg Utzinger
Marco Albonico
Jennifer Keiser
Public Health Laboratory Ivo de Carneri · TZSwiss Tropical and Public Health Institute · CHUniversity of Basel · CHInstitute for Scientific Interchange · ITToronto General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPathogenic intestinal protozoa infections are common in school-aged children in the developing world and they are frequently associated with malabsorption syndromes and gastrointestinal morbidity. Since diagnosis of these parasites is difficult, prevalence data on intestinal protozoa is scarce.

methodsWe collected two stool samples from school-aged children on Pemba Island, Tanzania, as part of a randomized controlled trial before and 3 weeks after treatment with (i) single-dose albendazole (400 mg); (ii) single-dose nitazoxanide (1,000 mg); (iii) nitazoxanide-albendazole combination (1,000 mg-400 mg), with each drug given separately on two consecutive days; and (iv) placebo. Formalin-fixed stool samples were examined for the presence of intestinal protozoa using an ether-concentration method to determine the prevalence and estimate cure rates (CRs).

resultsAlmost half (48.7%) of the children were diagnosed with at least one of the (potentially) pathogenic protozoa Giardia intestinalis, Entamoeba histolytica/E. dispar and Blastocystis hominis. Observed CRs were high for all treatment arms, including placebo. Nitazoxanide showed a significant effect compared to placebo against the non-pathogenic protozoon Entamoeba coli.

conclusionsIntestinal protozoa infections might be of substantial health relevance even in settings where they are not considered as a health problem. Examination of a single stool sample with the ether-concentration method lacks sensitivity for the diagnosis of intestinal protozoa, and hence, care is indicated when interpreting prevalence estimates and treatment effects.

Indexed as

AdolescentAlbendazoleAntiprotozoal AgentsBlastocystis hominisChildEntamoeba histolyticaFecesGastrointestinal DiseasesGiardia lambliaHumansIndian Ocean IslandsNitro CompoundsParasitic DiseasesParasitologyPlacebosPrevalenceAlbendazoleAntiprotozoal AgentsnitazoxanideNitro CompoundsPlacebosThiazoles

Identifiers

PMID23289920
PMCPMC3558385
OpenAlexW2135461233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.